Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin

Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14.

ESMO open·2025

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.

ESMO open·2023

Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.

ESMO open·2022

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.

ESMO open·2022

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients.

ESMO open·2021

Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-Analysis.

Neurology·2026

Longitudinal EEG, Seizure, and Developmental Patterns in Children With CDKL5 Deficiency Disorder in the First 2 Years of Life.

Neurology·2026

Linking Military Blast Exposure to Veterans Health Administration Diagnoses: Chronic Health Outcomes in the Millennium Cohort Study.

Neurology·2026

Clinical Reasoning: A 35-Year-Old Man Presenting With Chronic Left Foot Drop and Right Hand Weakness.

Neurology·2026

Pragmatic Frameworks for Clinical Compensation in Academic Neurology.

Neurology·2026

Retinal Optical Coherence Tomography-Angiography and Longitudinal Changes in Cognition and Cerebral Small Vessel Disease.

Neurology·2026

Hypochlorous acid irrigation reduces the rate of infections in patients undergoing implant-based breast reconstruction.

JPRAS open·2026

[A Case of Post-Transplant Lymphoproliferative Disorder with Suspected Thrombosis Leading to Discontinuation of Daprodustat Following Pharmacist Intervention].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study.

Arthritis & rheumatology (Hoboken, N.J.)·2026

[Detection of anti-Dia antibody in patients with cervical space-occupying lesions following massive blood transfusion].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2026

The Impact of Perioperative Immunosuppression on Post-surgical Outcomes in Patients with Inflammatory Bowel Disease.

Digestive diseases and sciences·2026

Intratumor delivery of a novel plasmid combination induces high levels of metastatic melanoma regression.

Gene therapy·2026

Related Experiment Videos

Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin

Related Concept Videos

Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14.

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.

Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.

Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients.

Factor XIa Inhibitors for Secondary Prevention After Noncardioembolic Stroke: A Systematic Review and Meta-Analysis.

Longitudinal EEG, Seizure, and Developmental Patterns in Children With CDKL5 Deficiency Disorder in the First 2 Years of Life.

Linking Military Blast Exposure to Veterans Health Administration Diagnoses: Chronic Health Outcomes in the Millennium Cohort Study.

Clinical Reasoning: A 35-Year-Old Man Presenting With Chronic Left Foot Drop and Right Hand Weakness.

Pragmatic Frameworks for Clinical Compensation in Academic Neurology.

Retinal Optical Coherence Tomography-Angiography and Longitudinal Changes in Cognition and Cerebral Small Vessel Disease.

Hypochlorous acid irrigation reduces the rate of infections in patients undergoing implant-based breast reconstruction.

[A Case of Post-Transplant Lymphoproliferative Disorder with Suspected Thrombosis Leading to Discontinuation of Daprodustat Following Pharmacist Intervention].

Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study.

[Detection of anti-Dia antibody in patients with cervical space-occupying lesions following massive blood transfusion].

The Impact of Perioperative Immunosuppression on Post-surgical Outcomes in Patients with Inflammatory Bowel Disease.

Intratumor delivery of a novel plasmid combination induces high levels of metastatic melanoma regression.

Related Experiment Videos

Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin

Related Concept Videos

Related Articles